Antec Scientific New Trade Name for Antec Leyden BV
Antec announced last March the corporate name change to Antec Scientific. The name change comes along with a new Corporate Identity and the launch of an updated website later this month.
Antec (Zoeterwoude, The Netherlands) announced last March the corporate name change to Antec Scientific. The name change comes along with a new Corporate Identity and the launch of an updated website later this month.
CEO Jean-Pierre Chervet said, “Over the last few years, Antec has become more and more scientifically engaged with national and international collaborations from academia and industry. Internships of young scientists such as masters, PhD fellows, post-docs, but also training of research fellows from industry in electrochemistry has become common practice at Antec. Furthermore, we have increased our focus on product innovation and new applications reflected in recent patent applications and granted patents.”
Martin Eysberg, Sales and Marketing Director, added, “We are very excited about the introduction of our new company name. We believe the name Antec Scientific allows us to better represent our business and reflects much better what we are doing, that is, not only manufacturing and selling scientific instruments but also the knowledge and expertise to become successful in the use of electrochemistry.”
“Changing our name to Antec Scientific formalizes a shift in corporate strategy that has been underway for several years and we will pursue this strategy to provide our customers with state-of-the-art electrochemical instruments as well as with the knowledge to become successful in the field,” said Nico Reinhoud, Managing Director of Antec.
For more information please visit www.AntecScientific.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
